ArdorComm Media Group

Sunday, March 15, 2026 5:42 AM

Health & Wellness Community

A health-tech startup that helps its patients in understanding prescriptions and also allows the doctor to predict the risk of cardiovascular disease

Health article

At the start of 2021 Tarun Gupta, was first presented with a new product at the AIIMS ophthalmology department. The product was a noninvasive retina screening tool thatwas capable of checking cardiovascular risk. At another experience where the eye drop prescription for Tarun’s son led him to give a one-month eye drop dosage for three months, resulting in damage of looks for his son. This situational crisis made Tarun understand the deep-rooted issue of difficulty in understanding the prescription written by doctors. That did lead to big blunders as well as irreversible damage to the patients. Therefore, with the motive of bridging the gap between understanding the prescription and decoding it correctly. Tarun Thakur, with his colleague Prakash Thakur, launched a healthcare startup SiCureMi, healthcare technologies, in late 2018. The motive behind this was to improve the health outcome and enhance the healthcare delivery. There have been cases where patients could not decide whether they needed to take a medicine once a day or twice a day. There were situations when old-aged patients took the night dose of medicine in the morning because they forgot to take it early, leading to dangerous conditions. Keeping these issues in mind, Tarun Gupta started this unique healthcare startup in 2018, the screening of the product began in 2019, and KYP was initiated in 2021 for the same. KYP by SiCureMi solutions is known as ‘Know your prescription’, which is a patient-focused production for explaining and simplifying the prescription and addressing general treatment-related queries in languages such as; English, Hindi, Punjabi, Bengali, and Malayalam. KYP helps to give clarity around the medical prescription. All a patient needs to do is visit the AI-based portal, which will direct the patient a WhatsApp number as due diligence. Then these patients are connected with a pharmacist or medical professional to assist them in giving a deep understanding of their prescription. This way, the new tool will result in minimizing medication errors and providing better patient adherence . Cardiac disease risk prediction The IIT Delhi incubation startup has designed an early diagnostic and AI and ML-based prevention screening tool to assess and manage chronic health conditions. The diseases that can be ordered and predicted by these AI and ML-based tool cardiovascular diseases are usually caused due to past reasons like hypertension, kidney disease, elevated levels of total cholesterol, and blood sugar level. However, the changes in the retinal microvasculature will give a better insight; hence, SiCureMi has built algorithm-based methods that can predict the risk scores. Ophthalmologists, cardiologists, and other related clinicians can utilize this risk assessment tool to assess early signs of potential risk. Source: Yourstory.com

A health-tech startup that helps its patients in understanding prescriptions and also allows the doctor to predict the risk of cardiovascular disease Read More »

As other vaccines lag, Serum Institute of India contributes the highest in the Vaccination drive

Till date, the country accounted 98.55 crore doses of Covid-19 vaccines given to the public. On Monday, 83.30 lakh doses were accounted till 7.15 PM. With this speed of vaccination in such a short period, the country is set to reach the 100-crore vaccination mark in the next few days. Among these doses, the maximum contribution of vaccines has come from the serum Institute of India (SII), which is nearly 88 % of the total vaccine doses given so far. Apart from that, almost 6.7 crore vaccines have been exported by the Serum Institute of India to other countries. Vaccination has been the most powerful tool to handle the pandemic so far. Till now, nearly 75 % of the population has got its first dose, whereas 30% of the population is now fully vaccinated. Along with that, more than 10.72 crore doses are still available with states and union territories. Serum Institute of India delivered more than it had committed and was a significant player in helping the government to run vaccination drives so effectively. Source: finacialexpress.com

As other vaccines lag, Serum Institute of India contributes the highest in the Vaccination drive Read More »

During the COVID-19 outbreak depression rate almost tripled in the USA

COVID -19 was made responsible for millions of deaths worldwide, but that’s not the only loss the pandemic has done to humanity. The Lancet Regional Health-Americas published a study report on how the COVID-19 pandemic has affected people’s mental health. The study has highlighted, the pandemic not just increased the rate of depression but the rise in number of cases is worse compared to other traumatic events like; weather, terror attack, or earlier pandemics. During this study, the author of the investigation by the Boston University School of Public Health (BUSPH) used the data collected on depression before and after the pandemic to compare the study. Participants filled a survey form to determine if they were suffering from any depression or not. In 2021, the survey showed that 32.8% of respondents had depression symptoms in 2021, which was 27.8% in 2020. Source: medicalnewstoday.com

During the COVID-19 outbreak depression rate almost tripled in the USA Read More »

As per the study, the risk of strokes and heart attacks can be lowered by maintaining an ideal sugar level

As per new research findings, people with diabetes and stroke may maintain an ideal sugar level to avoid the risk of different vascular diseases like a stroke or a heart attack later on. Findings of this research were published in the medical journey ‘Neurology.’ The study author Moon-Ku Han, MD, Ph.D., of Seoul National University College of Medicine in Korea, said, “Suffering from diabetes may lead to a higher risk of a heart attack. But as per our studies, optimum blood sugar level maylower the risk of getting another stroke, a heart attack or other vascular problems. This study involved 18,567 diabetic patients with an average age of 70. All the participants were admitted to the hospitals for an ischemic stroke caused by a blood clot. After admission, the researcher used a test called hemoglobin A1C to determine people’s blood sugar levels for the past two or three months. Participants had an average A1C of 7.5 percent. After observation of one year, it was found that there is an association between A1C level with risk of having another stroke, a heart attack or dying from these vascular causes. Source: Healthworld.com

As per the study, the risk of strokes and heart attacks can be lowered by maintaining an ideal sugar level Read More »

Schools with a mandate of the mask have been noticing fewer COVID-19 cases

A new research study from the centre for disease control and Prevention (CDC) has found that a mandate of wearing masks in schools plays a significant role in preventing COVID-19 cases among students. As per the CDC study, cases in children increased at a significant rate. The CDC studies pediatric COVID-19 rates from 520 counties where wearing a mask was consistent in all schools; it was applied to all schools consistently or to none of them. The CDC adjusted findings for controlling child vaccination rates for teachers and school testing data. In areas where the wearing mask was not mandatory, on average, there were 35 new pediatric cases per 100,000 children each day over two weeks of span. Source: healthline.com

Schools with a mandate of the mask have been noticing fewer COVID-19 cases Read More »

FDA Authorizes Booster Shots for people over 65-year age or one’s with a higher risk of Covid-19

The Food and Drug Administration (FDA) has given a Thumbs up for some special people to get the booster shots. Under this, people who have taken Pfizer-BioNTech vaccine atleast six months agoand those above the age of 65 or those at a higher risk of infection due to their previous medical reasons. Or elsethe ones suffering fromthe severe disease are eligible for getting this booster dose of vaccine. The news came in public a day after the FDA panel recommended that boosters be given to older adults and those at a high risk of infection. As per the research, protection provided by COVID-19 vaccines appears to wane over time, especially for people above the age of 65 and older. Source: healthline.com

FDA Authorizes Booster Shots for people over 65-year age or one’s with a higher risk of Covid-19 Read More »

One-third of Eds of Nifty 100 firm took a slash in remuneration in FY21

During this pandemic time, it was anticipated that around one-third of Executive Directorsof Nifty 100 companies had taken a cut in remuneration in 2020-21. The data compiled by primeinfobase.com on the compensation of executive directorsof Nifty 100 companiesshows that around 59 such people took a slash in their pay during the last fiscal year compared to 2019-20. The data available was for about 200 Executive directors of these firms. Some of them were either appointed in the middle of the year or ceased in the middle of the year. On the same note, around 17 of the 65 Nifty 100 companies for which data on median salaries got collected, there was a reduction in wages in the year 2020-21 compared to 2019-20. On average, most of Nifty 100 companies and top management saw an improvement in their remuneration last fiscal year despite being a pandemic hit a year, which brought the economy towards stability at least for the first four months of the year. Source: thehindubusinessline.com

One-third of Eds of Nifty 100 firm took a slash in remuneration in FY21 Read More »

Indian Government to Begin Vaccination Process for Children Between 12-18 Years

According to two sources who claim to have direct knowledge about the situation told Reuters that India is likely to start the vaccination process for children aged 12 years and above from mid-October 2021 when drugmaker Cadila Healthcare launches its ZyCoV-D product.   The world’s first DNA-based Covid-19 vaccine, ZyCoV-D won emergency authorisation from Indian regulators last month. From October, the company, better known as Zydus Cadila, will produce 10 million doses a month.   The Health Ministry did not immediately respond to a request for comment. The sources sought anonymity because they were not authorized to talk to the media. The vaccine is the only one approved for children in India, which has given a total of 825.9 million doses to adults among its population of nearly 1.4 billion.   If the vaccination for children begins in October, quite a lot of things will change in the country. If the student population receives a vaccination, schools will likely reopen for all in a hybrid or an in-person model. In some states, opening schools for children before vaccination has resulted in widespread COVID-19 infections amongst students. Therefore, the spread of the COVID-19 virus will lessen further if vaccinations are given to students below the age of 18 years.   Source: The article has been published by Reuters with additional inputs by the ArdorComm News Network team.

Indian Government to Begin Vaccination Process for Children Between 12-18 Years Read More »

Pfizer claims the Covid-19 vaccine safe for 5- to 11-year-old and shows robust antibody response.

In a recent announcement by Pfizer, it was claimed that a phase 2/3 trial showed its covid 19 vaccines are safe as well as generating robust antibody response in children aged between 5 to 11 years. Pfizer is the first ever to provide such results in terms of the Covid-19 vaccine for this particular age group, although the data has not yet been peer-reviewed or published. Pfizer has said that it is soon planning to submit a request for emergency use authorization to the US Food and Drug Administration. Which, FDA officials have communicated that once the report is submitted; the agency can authorize a vaccine for younger children within weeks. This trial of vaccine by Pfizer included 2,268 participants aged between 5 to 11 years, and a two-dose vaccine regimen was given and administered 21 days apart. Source: edituoncnn.com

Pfizer claims the Covid-19 vaccine safe for 5- to 11-year-old and shows robust antibody response. Read More »

Delhi: 53 Fresh Cases of Dengue Reported in the State, Cumulative Cases Rise To 211 This Year

Delhi: Dengue has been on the rise in India, and now, the nation’s capital Delhi is the new target. According to data, Delhi has recorded over 50 new Dengue cases in the past week. The total count for this year is a little more than 210. In addition, 87 new cases have been added till September 18, which is about 41 per cent of the total cumulative cases. Dengue cases have been at a record high from January 1- September 18. This number is the highest since 2019 when the reported cases were estimated to be around 217. Civic reports by municipal corporations show that 158 cases have been logged till September 11, 2021, and 53 new cases have been documented by the end of last week. In August, 78 new cases were reported in total. The death toll, so far, has been zero. According to reports, the month-wise distribution of cases is — January (0), February (2), March (5), April (10) and May (12), June (7) and July (16). In the previous years, the cases in the same period were — 1,375 (2016), 1,465 (2017), 343 (2018), 217 (2019) and 172 (2020). According to the civic report released on Monday, 86 cases of Malaria and 44 cases of Chikungunya have been reported till September 18, 2021. Source: Financial Express

Delhi: 53 Fresh Cases of Dengue Reported in the State, Cumulative Cases Rise To 211 This Year Read More »